Bio-Techne (Group)

https://www.bio-techne.com

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high quality purified proteins––notably cytokines and growth factors, antibodies, immunoassays, as well as biologically active small molecule compounds --- which are sold to biomedical researchers and clinical research laboratories; these operations constitute the core Biotech Division, headquartered in Minneapolis, Minnesota. The Protein Platform Division manufactures innovative protein analysis tools under the ProteinSimple brand name that greatly automate western blotting and immunoassay practices. The Diagnostics Division manufactures FDA-regulated controls, calibrators, blood gas and clinical chemistry controls for OEM customer and clinical customers. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $499 million in net sales in fiscal 2016 and has approximately 1,700 employees worldwide. *

	Start	2014-11-01 renamed
	Predecessor	Techne Corporation (Bio-Techne) (Group)
	Industry	diagnostics (medical/biological)
	Industry 2	reagents (bio/biochemical)
	Person	Kummeth, Charles R. (Chuck) (Techne Corp 201304– CEO before Thermo Fisher 201204 Pres Chromatography + MS + 3M Medical)

	Region	Minneapolis, MN
	Country	United States (USA)
	City	n. a. Minneapolis, MN
		Address record changed: 2020-12-02

Basic data	Employees	F: 1,001 to 5,000 (2022-06-30)
	Currency	USD
	Annual sales	1,105,599,000 (net sales (2022FY) 2022-06-30)
	Profit	263,099,000 (2022-06-30)
	Cash	172,567,000 (2022-06-30)

		* Document for »About Section«:

		Record changed: 2023-08-20